500.27 高血压小干扰 RNA (siRNA) 治疗剂 SA016 的临床前疗效和安全性

{"title":"500.27 高血压小干扰 RNA (siRNA) 治疗剂 SA016 的临床前疗效和安全性","authors":"Ping Chen, Nan Liu, Hongli Zhang, Hui Chen, Zhiwei Yang","doi":"10.1016/j.jcin.2024.01.206","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":14666,"journal":{"name":"JACC: Cardiovascular Interventions","volume":"39 22","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"500.27 The Preclinical Efficacy and Safety of SA016, a Small Interfering RNA (siRNA) Therapeutic Agent in Hypertension\",\"authors\":\"Ping Chen, Nan Liu, Hongli Zhang, Hui Chen, Zhiwei Yang\",\"doi\":\"10.1016/j.jcin.2024.01.206\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":14666,\"journal\":{\"name\":\"JACC: Cardiovascular Interventions\",\"volume\":\"39 22\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JACC: Cardiovascular Interventions\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.jcin.2024.01.206\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JACC: Cardiovascular Interventions","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.jcin.2024.01.206","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}